Barrett Business Services, Inc. Expected to Earn FY2022 Earnings of $6.62 Per Share (NASDAQ:BBSI)

Barrett Business Services, Inc. (NASDAQ:BBSI – Get Rating) – Barrington Research raised their FY2022 earnings per share (EPS) estimates for shares of Barrett Business Services in a research note issued to investors on Thursday, November 3rd. Barrington Research analyst V. Colicchio now forecasts that the business services provider will post earnings per share of $6.62 for the year, up from their previous estimate of $6.30. The consensus estimate for Barrett Business Services’ current full-year earnings is $6.55 per share. Barrington Research also issued estimates for Barrett Business Services’ FY2023 earnings at $7.20 EPS.

Several other research firms have also issued

Read more

Barrett Business Services Third Quarter 2022 Earnings: EPS Beats Expectations

Barrett Business Services (NASDAQ:BBSI) Third Quarter 2022 Results

Key Financial Results

  • Revenue: US$273.8m (up 11% from 3Q 2021).
  • Net income: US$17.4m (up 17% from 3Q 2021).
  • Profit margin: 6.4% (up from 6.0% in 3Q 2021). The increase in margin was driven by higher revenue.
  • EPS: US$2.48 (up from US$1.98 in 3Q 2021).
NasdaqGS:BBSI Earnings and Revenue Growth November 4th 2022

All figures shown in the chart above are for the trailing 12 month (TTM) period

Barrett Business Services EPS Beats Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 9.7%.

Looking ahead, revenue

Read more

Stocks fall, yields rise as investors pore over corporate earnings

U.S. stocks snapped a winning streak to end a back-and-forth session lower Wednesday as a rally that kicked off the week faltered despite better-than-feared earnings reports.

The S&P 500 (^GSPC) sank 0.7% after the index gained more than 4% in the past two days, while the Dow Jones Industrial Average (^DJI) shed around 100 points, or 0.3%. The technology-heavy Nasdaq Composite (^IXIC) was off by 0.9%. Meanwhile, the benchmark 10-year Treasury note spiked above 4.1%.

Netflix (NFLX) was in the spotlight following a big earnings beat Tuesday afternoon that included 2.41 million new subscribers – a key metric watched by

Read more

WRAPUP 2-Canada’s CIBC, TD earnings beat estimates but diverge on loan growth

(Adds share prices, comment from CIBC analyst call, context)

By Nichola Saminather

TORONTO, Aug 26 (Reuters) – Toronto-Dominion Bank (TD) and Canadian Imperial Bank of Commerce (CIBC) closed out Canadian lenders’ third-quarter results reporting with better-than-expected profits on Thursday, driven mostly by releases of reserves to cover bad loans, but CIBC’s strong loan growth from a year earlier eluded TD.

CIBC’s loan balances climbed 8% as of July 31, while TD’s fell 0.5% from a year earlier, as declines in the latter’s U.S. lending offset strong loan growth in Canada. This contributed to flat revenues at TD, while CIBC’s rose

Read more

VMware Earnings Beat Expectations. Why Its Stock Is Tumbling.

Text size

Revenue from the cloud business was lower than expected.

Yury Cherenkov/


shares are trading lower late Thursday after the enterprise software provider posted mixed results for its fiscal second quarter.

For the quarter ended July 30, VMware (ticker: VMW) reported revenue of $3.14 billion, in line with Street estimates. But investors may not have liked the component parts. 

License revenue, from the company’s traditional on premise software business,- was $738 million, up 3%, and ahead of the Street consensus forecast of $699 million. But subscription and software-as-a-service revenue—basically the company’s cloud business—was $776 million, up 23%, but

Read more

Sonnet BioTherapeutics Provides Fiscal Year 2021 Third Quarter Business and Earnings Update

Sonnet BioTherapeutics Provides Fiscal Year 2021 Third Quarter Business and Earnings Update

  • Expanded F H AB Intellectual Property Portfolio

  • Completed $15.9 million At-The-Market Financing

  • SON-1010 and SON-080 on track for IND submissions by calendar year end

PRINCETON, NJ / ACCESSWIRE / August 16, 2021 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (“Sonnet” or the “Company”), a biopharmaceutical company developing innovative targeted biologic drugs, announced today its financial results for the three months ended June 30th , 2021 and provided a business update.

“Throughout the quarter, we’ve continued to make several advancements towards the clinic with our proprietary Fully Human Albumin

Read more

Business Services Q2 Earnings on Aug 10: JAMF, FLYW & More

The widely diversified business services sector steadily gathered steam through the second quarter of 2021, backed by strength across both manufacturing and non-manufacturing activities, relaxation of restrictions and increased vaccination drives.

The quarter witnessed growth in major manufacturing industries like machinery; electrical equipment, appliances & components; transportation equipment, food, beverage & tobacco products; printing & related support activities; computer & electronic products; and petroleum & coal products.

Among services industries, notable growth came in from retail trade; wholesale trade; transportation & warehousing; management of companies & support services; accommodation & food services; mining; utilities; construction; health care & social assistance;

Read more